US Trauma Device Market to See Steady Growth to $3.9 Billion by 2017

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US trauma device market will grow at a steady pace through 2017. Pricing pressures will limit average selling prices but an increase in the size of the elderly population and the related increase in the incidence of osteoporosis will drive an expansion of procedure volumes. Coupled with the adoption of some premium-priced products, this will lead to an increase in market size to nearly $3.9 billion in 2017.

“Industry sources have indicated that sales have suffered for some of these competitors due to concerns regarding integration of existing product lines and sales forces, as well as preserving customer bases.”

An increasing number of surgeons are undergoing manufacturer-sponsored training on the use of specialized trauma devices. These trauma devices are generally less invasive, reducing operative trauma and patient discomfort while shortening recovery times. One example of a device designed for this approach is intramedullary (IM) nails, which can be inserted percutaneously. Adoption of such premium-priced devices will help support average selling prices.

After a long period of stability, mergers and acquisitions have shaken up the trauma device market. The biggest event came as Johnson & Johnson (DePuy’s parent company) finalized its acquisition of Synthes. As a condition of the deal, DePuy sold off its trauma product line to Biomet. In the long-bone growth stimulators market, Smith & Nephew divested its EXOGEN product line to Bioventus. These acquisitions have resulted in a reconfiguring of the competitive landscape of the US trauma device market.

“These mergers have not been accomplished without cost,” said MRG Analyst Daniel Brown. “Industry sources have indicated that sales have suffered for some of these competitors due to concerns regarding integration of existing product lines and sales forces, as well as preserving customer bases.”

Millennium Research Group’s US Markets for Trauma Devices 2013 report includes procedure, unit, average selling price, and revenue information, along with market drivers and limiters and competitive landscape for plates and screws, intramedullary (IM) nails, cannulated screws, dynamic hip screws, ancillary trauma devices, external fixation devices, and long-bone growth stimulation devices in the United States.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.